The forecast for antibacterial medicine use in Belgium shows a consistent decreasing trend from 2024 to 2028, with annual values slightly declining each year. Specifically, the values drop from 21.0 in 2024 to 20.6 in 2028, representing an annual decrease of approximately 0.5% year-on-year. Compared to 2023, there is a similar pattern observed, with values steadily reducing year over year. The five-year compound annual growth rate (CAGR) over this period reflects a near-stable, yet modest, decline in antibacterial medicine usage.
Future trends to watch for include advancements in antimicrobial resistance, changes in public health policies aimed at reducing unnecessary antibiotic prescriptions, and innovations in alternative treatments. Monitoring these factors will be crucial in understanding the trajectory of antibacterial medicine use in Belgium. The impact of global health initiatives and educational campaigns on responsible antibiotic use will also be significant in shaping future usage patterns.
